TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Thomas Jiborn Medicinkonsult AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
10
|
13
|
12 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
6
|
10
![]() |
10 |
EBITDA |
6
|
10
![]() |
10 |
Total assets |
13
|
16
![]() |
16 |
Current assets |
13
|
16
![]() |
16 |
Current liabilities |
3
![]() |
3
![]() |
3 |
Equity capital |
10
|
13
![]() |
13 |
- share capital |
5
|
4
|
5 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
76.9%
|
81.2%
![]() |
81.2% |
Turnover per employee |
10
|
13
|
12 |
Profit as a percentage of turnover |
60.0%
|
76.9%
|
83.3% |
Return on assets (ROA) |
46.2%
|
62.5%
![]() |
62.5% |
Current ratio |
433.3%
|
533.3%
![]() |
533.3% |
Return on equity (ROE) |
60.0%
|
76.9%
![]() |
76.9% |
Change turnover |
-4
|
2
|
1 |
Change turnover % |
-26%
|
19%
|
7% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.